P - D3 - P001 - 025
Treatment of lipolysis-stimulated lipoprotein receptor (LSR) antibody with HDAC inhibitors promotes apoptosis in human salivary duct adenocarcinoma
Soshi Nishida
(Department of Cell Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan | Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Masaya Nakano
(Department of Cell Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan | Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Kizuku Ohwada
(Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Takumi Konno
(Department of Cell Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Takayuki Kohno
(Department of Cell Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Akito Kakiuchi
(Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Kazufumi Obata
(Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Makoto Kurose
(Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Kenichi Takano
(Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)
、
Takashi Kojima
(Department of Cell Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan)